Tapewire

NYSE · USD

CVS

CVS HEALTH Corp

Export transactions ↓
Tapewire entity
2884
SEC CIK
0000064803
Parsed reports
1,748

Last 12 months

Inside the activity.

0 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202608
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 22, 2007 Filed Mar 26, 2007 20:49 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
GrantStock Option · Derivative 374,879 $0.00 Strike: $20.23 $0.00
Disclosure

SEC source: 0000064803-07-000065 · doc.xml · derivative · entry 8

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 374,879

Underlying: Common Stock · 374,879 shares

Expires 2015-03-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:49 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
GrantStock Option · Derivative 374,717 $0.00 Strike: $17.08 $0.00
Disclosure

SEC source: 0000064803-07-000065 · doc.xml · derivative · entry 7

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 374,717

Underlying: Common Stock · 374,717 shares

Expires 2014-05-10

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:49 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
GrantStock Option · Derivative 65,579 $0.00 Strike: $9.78 $0.00
Disclosure

SEC source: 0000064803-07-000065 · doc.xml · derivative · entry 6

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,579

Underlying: Common Stock · 65,579 shares

Expires 2013-04-02

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:49 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
GrantStock Option · Derivative 187,391 $0.00 Strike: $7.04 $0.00
Disclosure

SEC source: 0000064803-07-000065 · doc.xml · derivative · entry 5

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,391

Underlying: Common Stock · 187,391 shares

Expires 2011-11-07

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:49 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
GrantStock Option · Derivative 93,692 $0.00 Strike: $6.46 $0.00
Disclosure

SEC source: 0000064803-07-000065 · doc.xml · derivative · entry 4

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,692

Underlying: Common Stock · 93,692 shares

Expires 2010-11-15

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:49 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
GrantCommon Stock 3,340 $34.80 $116,232.00
Disclosure

SEC source: 0000064803-07-000065 · doc.xml · nonDerivative · entry 3

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Indirect · IRA

Disclosed balance after: 3,340

F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:49 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
GrantCommon Stock 2,505 $34.80 $87,174.00
Disclosure

SEC source: 0000064803-07-000065 · doc.xml · nonDerivative · entry 2

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 2,505

F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:49 UTC
MCLURE HOWARD APresident, Caremark Pharm Serv
GrantCommon Stock (Restricted) 67,198 $0.00 $0.00
Disclosure

SEC source: 0000064803-07-000065 · doc.xml · nonDerivative · entry 1

MCLURE HOWARD A · CIK 0001197690 · President, Caremark Pharm Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,198

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC GrantStock Option · Derivative 33,726 $0.00 Strike: $27.12 $0.00
Disclosure

SEC source: 0000064803-07-000066 · doc.xml · derivative · entry 6

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,726

Underlying: Common Stock · 33,726 shares

Expires 2016-03-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC GrantStock Option · Derivative 33,739 $0.00 Strike: $20.23 $0.00
Disclosure

SEC source: 0000064803-07-000066 · doc.xml · derivative · entry 5

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,739

Underlying: Common Stock · 33,739 shares

Expires 2015-03-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC GrantStock Option · Derivative 5,404 $0.00 Strike: $18.05 $0.00
Disclosure

SEC source: 0000064803-07-000066 · doc.xml · derivative · entry 4

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,404

Underlying: Common Stock · 5,404 shares

Expires 2014-04-30

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC GrantStock Option · Derivative 22,960 $0.00 Strike: $7.11 $0.00
Disclosure

SEC source: 0000064803-07-000066 · doc.xml · derivative · entry 3

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,960

Underlying: Common Stock · 22,960 shares

Expires 2011-12-20

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC GrantCommon Stock 8,946 $34.80 $311,320.80
Disclosure

SEC source: 0000064803-07-000066 · doc.xml · nonDerivative · entry 2

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,260

F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC GrantCommon Stock 32,314 $34.80 $1,124,527.20
Disclosure

SEC source: 0000064803-07-000066 · doc.xml · nonDerivative · entry 1

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,314

F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC GrantCommon Stock 668 $34.80 $23,246.40
Disclosure

SEC source: 0000064803-07-000067 · doc.xml · nonDerivative · entry 2

MURRAY TERRENCE · CIK 0001196361 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Membership

Disclosed balance after: 2,148

F2 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark shares owned by the reporting person to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC
PICCOLO C ADirector
GrantStock Option · Derivative 33,726 $0.00 Strike: $27.12 $0.00
Disclosure

SEC source: 0000064803-07-000068 · doc.xml · derivative · entry 7

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,726

Underlying: Common Stock · 33,726 shares

Expires 2016-03-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC
PICCOLO C ADirector
GrantStock Option · Derivative 33,739 $0.00 Strike: $20.23 $0.00
Disclosure

SEC source: 0000064803-07-000068 · doc.xml · derivative · entry 6

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,739

Underlying: Common Stock · 33,739 shares

Expires 2015-03-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC
PICCOLO C ADirector
GrantStock Option · Derivative 46,856 $0.00 Strike: $13.41 $0.00
Disclosure

SEC source: 0000064803-07-000068 · doc.xml · derivative · entry 5

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,856

Underlying: Common Stock · 46,856 shares

Expires 2014-01-02

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC
PICCOLO C ADirector
GrantStock Option · Derivative 46,849 $0.00 Strike: $9.17 $0.00
Disclosure

SEC source: 0000064803-07-000068 · doc.xml · derivative · entry 4

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,849

Underlying: Common Stock · 46,849 shares

Expires 2013-02-25

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC
PICCOLO C ADirector
GrantStock Option · Derivative 46,844 $0.00 Strike: $8.42 $0.00
Disclosure

SEC source: 0000064803-07-000068 · doc.xml · derivative · entry 3

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,844

Underlying: Common Stock · 46,844 shares

Expires 2012-01-02

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC
PICCOLO C ADirector
GrantCommon Stock 17,691 $34.80 $615,646.80
Disclosure

SEC source: 0000064803-07-000068 · doc.xml · nonDerivative · entry 2

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,711

F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC
PICCOLO C ADirector
GrantCommon Stock 143,020 $34.80 $4,977,096.00
Disclosure

SEC source: 0000064803-07-000068 · doc.xml · nonDerivative · entry 1

PICCOLO C A · CIK 0001192152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,020

F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC
Spalding William REVP Caremark Pharmacy Services
GrantStock Option · Derivative 234,212 $0.00 Strike: $27.12 $0.00
Disclosure

SEC source: 0000064803-07-000069 · doc.xml · derivative · entry 4

Spalding William R · CIK 0001331844 · EVP Caremark Pharmacy Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,212

Underlying: Common Stock · 234,212 shares

Expires 2016-03-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC
Spalding William REVP Caremark Pharmacy Services
GrantStock Option · Derivative 936,944 $0.00 Strike: $23.54 $0.00
Disclosure

SEC source: 0000064803-07-000069 · doc.xml · derivative · entry 3

Spalding William R · CIK 0001331844 · EVP Caremark Pharmacy Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 936,944

Underlying: Common Stock · 936,944 shares

Expires 2015-06-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC
Spalding William REVP Caremark Pharmacy Services
GrantCommon Stock (Restricted) 23,185 $0.00 $0.00
Disclosure

SEC source: 0000064803-07-000069 · doc.xml · nonDerivative · entry 2

Spalding William R · CIK 0001331844 · EVP Caremark Pharmacy Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,185

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:50 UTC
Spalding William REVP Caremark Pharmacy Services
GrantCommon Stock 182 $34.80 $6,333.60
Disclosure

SEC source: 0000064803-07-000069 · doc.xml · nonDerivative · entry 1

Spalding William R · CIK 0001331844 · EVP Caremark Pharmacy Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182

F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:51 UTC GrantStock Option · Derivative 33,726 $0.00 Strike: $27.12 $0.00
Disclosure

SEC source: 0000064803-07-000070 · doc.xml · derivative · entry 5

WILLIAMS KRISTEN GIBNEY · CIK 0001197683 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,726

Underlying: Common Stock · 33,726 shares

Expires 2016-03-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:51 UTC GrantStock Option · Derivative 46,856 $0.00 Strike: $13.41 $0.00
Disclosure

SEC source: 0000064803-07-000070 · doc.xml · derivative · entry 4

WILLIAMS KRISTEN GIBNEY · CIK 0001197683 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,856

Underlying: Common Stock · 46,856 shares

Expires 2014-01-02

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:51 UTC GrantStock Option · Derivative 46,849 $0.00 Strike: $9.17 $0.00
Disclosure

SEC source: 0000064803-07-000070 · doc.xml · derivative · entry 3

WILLIAMS KRISTEN GIBNEY · CIK 0001197683 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,849

Underlying: Common Stock · 46,849 shares

Expires 2013-02-25

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:51 UTC GrantCommon Stock 16,700 $34.80 $581,160.00
Disclosure

SEC source: 0000064803-07-000070 · doc.xml · nonDerivative · entry 2

WILLIAMS KRISTEN GIBNEY · CIK 0001197683 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,640

F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:51 UTC GrantCommon Stock 22,940 $34.80 $798,312.00
Disclosure

SEC source: 0000064803-07-000070 · doc.xml · nonDerivative · entry 1

WILLIAMS KRISTEN GIBNEY · CIK 0001197683 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,940

F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:53 UTC
CRAWFORD EDWIN MDirector · Chairman
GrantStock Option · Derivative 843,164 $0.00 Strike: $27.12 $0.00
Disclosure

SEC source: 0000064803-07-000071 · doc.xml · derivative · entry 7

CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 843,164

Underlying: Common Stock · 843,164 shares

Expires 2016-03-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:53 UTC
CRAWFORD EDWIN MDirector · Chairman
GrantStock Option · Derivative 1,405,799 $0.00 Strike: $20.23 $0.00
Disclosure

SEC source: 0000064803-07-000071 · doc.xml · derivative · entry 6

CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,405,799

Underlying: Common Stock · 1,405,799 shares

Expires 2015-03-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:53 UTC
CRAWFORD EDWIN MDirector · Chairman
GrantStock Option · Derivative 1,124,153 $0.00 Strike: $17.08 $0.00
Disclosure

SEC source: 0000064803-07-000071 · doc.xml · derivative · entry 5

CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,124,153

Underlying: Common Stock · 1,124,153 shares

Expires 2014-05-10

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:53 UTC
CRAWFORD EDWIN MDirector · Chairman
GrantStock Option · Derivative 3,017,937 $0.00 Strike: $8.99 $0.00
Disclosure

SEC source: 0000064803-07-000071 · doc.xml · derivative · entry 4

CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,017,937

Underlying: Common Stock · 3,017,937 shares

Expires 2011-08-28

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:53 UTC
CRAWFORD EDWIN MDirector · Chairman
GrantStock Option · Derivative 3,794,611 $0.00 Strike: $2.37 $0.00
Disclosure

SEC source: 0000064803-07-000071 · doc.xml · derivative · entry 3

CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,794,611

Underlying: Common Stock · 3,794,611 shares

Expires 2010-03-08

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:53 UTC
CRAWFORD EDWIN MDirector · Chairman
GrantStock Option · Derivative 1,874 $0.00 Strike: $1.60 $0.00
Disclosure

SEC source: 0000064803-07-000071 · doc.xml · derivative · entry 2

CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,874

Underlying: Common Stock · 1,874 shares

Expires 2008-09-21

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 20:53 UTC
CRAWFORD EDWIN MDirector · Chairman
GrantCommon Stock 133,600 $34.80 $4,649,280.00
Disclosure

SEC source: 0000064803-07-000071 · doc.xml · nonDerivative · entry 1

CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,600

F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 23:24 UTC GrantStock Option · Derivative 33,726 $0.00 Strike: $27.12 $0.00
Disclosure

SEC source: 0000064803-07-000072 · doc.xml · derivative · entry 9

HEADRICK ROGER L · CIK 0001192145 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,726

Underlying: Common Stock · 33,726 shares

Expires 2016-03-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 23:24 UTC GrantStock Option · Derivative 33,739 $0.00 Strike: $20.23 $0.00
Disclosure

SEC source: 0000064803-07-000072 · doc.xml · derivative · entry 8

HEADRICK ROGER L · CIK 0001192145 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,739

Underlying: Common Stock · 33,739 shares

Expires 2015-03-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 23:24 UTC GrantStock Option · Derivative 46,856 $0.00 Strike: $13.41 $0.00
Disclosure

SEC source: 0000064803-07-000072 · doc.xml · derivative · entry 7

HEADRICK ROGER L · CIK 0001192145 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,856

Underlying: Common Stock · 46,856 shares

Expires 2014-01-02

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 23:24 UTC GrantStock Option · Derivative 46,844 $0.00 Strike: $8.42 $0.00
Disclosure

SEC source: 0000064803-07-000072 · doc.xml · derivative · entry 6

HEADRICK ROGER L · CIK 0001192145 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,844

Underlying: Common Stock · 46,844 shares

Expires 2012-01-02

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 23:24 UTC GrantStock Option · Derivative 46,851 $0.00 Strike: $6.53 $0.00
Disclosure

SEC source: 0000064803-07-000072 · doc.xml · derivative · entry 5

HEADRICK ROGER L · CIK 0001192145 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,851

Underlying: Common Stock · 46,851 shares

Expires 2011-01-12

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 23:24 UTC GrantShare Credits · Derivative 46,849 $0.00 Strike: $9.17 $0.00
Disclosure

SEC source: 0000064803-07-000072 · doc.xml · derivative · entry 4

HEADRICK ROGER L · CIK 0001192145 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,849

Underlying: Common Stock · 46,849 shares

Expires 2013-02-25

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 23:24 UTC GrantCommon Stock 2,087 $34.80 $72,627.60
Disclosure

SEC source: 0000064803-07-000072 · doc.xml · nonDerivative · entry 3

HEADRICK ROGER L · CIK 0001192145 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Spouse

Disclosed balance after: 2,087

F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 23:24 UTC GrantCommon Stock 29,313 $34.80 $1,020,092.40
Disclosure

SEC source: 0000064803-07-000072 · doc.xml · nonDerivative · entry 2

HEADRICK ROGER L · CIK 0001192145 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,873

F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 23:24 UTC GrantCommon Stock 280,560 $34.80 $9,763,488.00
Disclosure

SEC source: 0000064803-07-000072 · doc.xml · nonDerivative · entry 1

HEADRICK ROGER L · CIK 0001192145 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,560

F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 23:25 UTC GrantStock Option · Derivative 33,726 $0.00 Strike: $27.12 $0.00
Disclosure

SEC source: 0000064803-07-000073 · doc.xml · derivative · entry 6

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,726

Underlying: Common Stock · 33,726 shares

Expires 2016-03-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 23:25 UTC GrantStock Option · Derivative 33,739 $0.00 Strike: $20.23 $0.00
Disclosure

SEC source: 0000064803-07-000073 · doc.xml · derivative · entry 5

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,739

Underlying: Common Stock · 33,739 shares

Expires 2015-03-01

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document
March 22, 2007 Filed Mar 26, 2007 23:25 UTC GrantStock Option · Derivative 5,404 $0.00 Strike: $18.05 $0.00
Disclosure

SEC source: 0000064803-07-000073 · doc.xml · derivative · entry 4

MILLON JEAN PIERRE · CIK 0001190016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,404

Underlying: Common Stock · 5,404 shares

Expires 2014-04-30

F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.